IT Quiz Answer – August 22, 2024

Answers from our weekly Intelligent Thursday quizzes!

Franz Wiesbauer, MD MPH
Franz Wiesbauer, MD MPH
16th Aug 2024 • 1m read

Pop quiz: August 22, 2024

The NOACs (new oral anticoagulants) are now preferred over warfarin for anticoagulation therapy. Why?

Answer: B & C

Explanation: 

As of 2019, the American College of Cardiology and American Heart Association guidelines recommend NOACs over warfarin for anticoagulation therapy. There are a number of reasons for this, including more predictable pharmacokinetics, quicker onset, no interaction with foods, and a reduced rate of intracranial and severe bleeding events, but they are only beneficial for certain patient populations. NOACs should not be used in individuals with valvular atrial fibrillation and because of the involvement of the kidneys and liver in the metabolism of NOACs, patients with liver disease or end-stage renal disease should be prescribed warfarin or apixaban.​

​​

Not the answer you expected? Start our Atrial Fibrillation Management Essentials course now! Not sure when to use rhythm control or rate control, and what type of anticoagulants to prescribe? Do you wonder if your patient is a good candidate for ablation? In this course, we are going to clarify the atrial fibrillation guidelines and evidence so that you can treat AF with confidence.